50 mg vial 4 mL 2.5 mg dose Concentration: 50 mg 4 mL = 12.5 mg/mL
Composition-documented, HPLC-verified by component, and dispatched within 48 hours
You can wait for the soreness to go away on its own, or you can treat it with a cool compress
Therapeutic Applications and Considerations BPC 157 is explored for several recovery-related use cases, including joint support, soft-tissue healing, gastrointestinal irritation, and mucosal repair
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary